ALKEM
Alkem Laboratories Limited
Pharmaceuticals
Share price
₹5,050
Market cap
₹60,435 Cr
1Y return
▼ 8%
A pharmaceutical company engaged in the development, manufacture, and sale of drugs and nutraceutical products across global markets. The company operates research-driven facilities to serve both domestic and international customers with a focus on therapeutic innovation. Its distinctive approach combines pharmaceutical manufacturing expertise with nutraceutical offerings to address diverse healthcare needs and patient populations worldwide.
Investors holding Alkem Laboratories Limited
5.35%
2.68%
2.25%
1.99%
1.34%
1.17%
Recent moves 24
Moves24
HDFC Life Insurance
15 Oct 2026. Sign in to see this move
SBI Mutual Fund
15 Oct 2026. Sign in to see this move
LIC
15 Oct 2026. Sign in to see this move
HDFC Mutual Fund
15 Oct 2026. Sign in to see this move
Nippon India Mutual Fund
15 Oct 2026. Sign in to see this move
ICICI Prudential Mutual Fund
15 Oct 2026. Sign in to see this move
DSP Mutual Fund
15 Oct 2026. Sign in to see this move
HDFC Mutual FundIncreased
HDFC Mutual Fund bought 25,019 shares of Alkem Laboratories in the open market. This purchase raised its stake from 5.00% to 5.02%, crossing the 5% disclosure threshold.
Read more
LICDecreased
LIC decreased its stake in Alkem Laboratories by selling 147,955 shares, reducing its holding from 1.56% to 1.43%. The value of the shares sold is ₹82.26 crore at ₹5563.00 apiece.
Read more
SBI Mutual FundDecreased
SBI Mutual Fund decreased its stake in Alkem Laboratories from 2.42% to 1.99%, selling 508,608 shares for ₹283.05 crore at ₹5563.00 apiece.
Read more
Track the whales in Alkem Laboratories Limited
Get alerted the moment a top investor buys or sells.
Get started